Invention Grant
- Patent Title: Rationally-designed anti-mullerian inhibiting substance type II receptor antibodies
-
Application No.: US14122286Application Date: 2012-05-29
-
Publication No.: US09611321B2Publication Date: 2017-04-04
- Inventor: Gregory P. Adams , Heidi H. Simmons , Matthew K. Robinson , Roland Dunbrack , Andreas Lehmann
- Applicant: Gregory P. Adams , Heidi H. Simmons , Matthew K. Robinson , Roland Dunbrack , Andreas Lehmann
- Applicant Address: US PA Philadelphia
- Assignee: Fox Chase Cancer Center
- Current Assignee: Fox Chase Cancer Center
- Current Assignee Address: US PA Philadelphia
- Agency: Dann, Dorfman, Herrell and Skillman
- Agent Robert C. Netter, Jr.
- International Application: PCT/US2012/039831 WO 20120529
- International Announcement: WO2012/166712 WO 20121206
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/44 ; C07K16/46 ; A61K39/395 ; A61K45/06
Abstract:
Methods for generating hybrid antibodies are provided.
Public/Granted literature
- US20140234213A1 Rationally-Designed Anti-Mullerian Inhibiting Substance Type II Receptor Antibodies Public/Granted day:2014-08-21
Information query
